low dose glp 1 agonist GLP-1s Microdosed GLP-1 (Semaglutide)
Description
Sleep Apnea and Kidney Disease Separate ongoing TRIUMPH Phase 3 trials are evaluating retatrutide in patients with moderate-to-severe obstructive sleep apnea and in adults with chronic kidney disease and obesity
9: e70070
Mechanism Although the exact mechanisms underlying GLP-1 RA-induced diabetic retinopathy remain unclear, several hypotheses have been proposed
It required prior authorization
This study showed a mean weight reduction of 10%, and significant reductions in triglyceride, total cholesterol, and LDL-C levels of 25%, 11%, and 11% respectively [32]
